Ionis Pharmaceuticals Inc (IONS)
38.50
+1.20
(+3.20%)
USD |
NASDAQ |
May 20, 14:05
Ionis Pharmaceuticals Free Cash Flow: -345.48M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -345.48M |
December 31, 2023 | -335.52M |
September 30, 2023 | -573.62M |
June 30, 2023 | -492.84M |
March 31, 2023 | -405.00M |
December 31, 2022 | -294.47M |
September 30, 2022 | 110.43M |
June 30, 2022 | 81.74M |
March 31, 2022 | 35.38M |
December 31, 2021 | 12.90M |
September 30, 2021 | -95.70M |
June 30, 2021 | -58.77M |
March 31, 2021 | -45.24M |
December 31, 2020 | -5.156M |
September 30, 2020 | 172.64M |
June 30, 2020 | 165.29M |
March 31, 2020 | 188.32M |
December 31, 2019 | 309.34M |
September 30, 2019 | 153.84M |
June 30, 2019 | 153.72M |
March 31, 2019 | 678.61M |
December 31, 2018 | 585.25M |
September 30, 2018 | 485.20M |
June 30, 2018 | 524.88M |
March 31, 2018 | 27.93M |
Date | Value |
---|---|
December 31, 2017 | 136.29M |
September 30, 2017 | 92.28M |
June 30, 2017 | 105.36M |
March 31, 2017 | 71.59M |
December 31, 2016 | -123.63M |
September 30, 2016 | -133.56M |
June 30, 2016 | -122.32M |
March 31, 2016 | -22.98M |
December 31, 2015 | 9.377M |
September 30, 2015 | 115.98M |
June 30, 2015 | 83.11M |
March 31, 2015 | -15.18M |
December 31, 2014 | -4.819M |
September 30, 2014 | -86.83M |
June 30, 2014 | -23.50M |
March 31, 2014 | 35.57M |
December 31, 2013 | 58.13M |
September 30, 2013 | 108.83M |
June 30, 2013 | 18.85M |
March 31, 2013 | -7.621M |
December 31, 2012 | -3.294M |
September 30, 2012 | -63.10M |
June 30, 2012 | -63.79M |
March 31, 2012 | -90.04M |
December 31, 2011 | -125.80M |
Free Cash Flow Range, Past 5 Years
-573.62M
Minimum
Sep 2023
309.34M
Maximum
Dec 2019
-63.41M
Average
3.871M
Median
Free Cash Flow Benchmarks
Biogen Inc | 1.284B |
Viking Therapeutics Inc | -54.87M |
Madrigal Pharmaceuticals Inc | -391.12M |
Akero Therapeutics Inc | -155.88M |
89bio Inc | -138.82M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -149.94M |
Cash from Investing (Quarterly) | 76.10M |
Cash from Financing (Quarterly) | 23.57M |
Free Cash Flow Per Share (Quarterly) | -1.070 |
Free Cash Flow to Equity (Quarterly) | -148.31M |
Free Cash Flow to Firm (Quarterly) | -133.55M |
Free Cash Flow Yield | -6.24% |